Neurovascular Thrombectomy Device Market

Neurovascular Thrombectomy Device Market Study by Stent Retrievers and Aspiration Catheters for Hospitals, Neuro-Catheterization Labs, and Specialized Neurosurgery Centres from 2024 to 2034

Analysis of Neurovascular Thrombectomy Device Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Neurovascular Thrombectomy Device Market Outlook (2024 to 2034)

The global neurovascular thrombectomy device market is expected to be worth US$ 744.6 million in 2024 and is forecast to reach a value of US$ 1,439.6 million by 2034, with a projected CAGR of 6.8% from 2024 to 2034.

The market is witnessing significant growth due to advancements in medical technology and an increasing prevalence of cerebrovascular diseases. These devices are crucial in treating conditions such as stroke, where blood clots obstruct blood vessels in the brain.

The rising aging population, coupled with lifestyle factors contributing to vascular disorders, propels the demand for neurovascular thrombectomy devices. Key players focus on innovation, developing minimally invasive and efficient devices to enhance patient outcomes.

A growing awareness of the importance of timely intervention in neurovascular emergencies further drives the market's expansion. As healthcare systems prioritize efficient stroke care, the market is poised for sustained development, offering improved solutions for patients facing neurovascular challenges.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Key Market Growth Drivers

  • The rising prevalence of cerebrovascular diseases, such as strokes, drives the growth of the neurovascular thrombectomy device market as a vital tool in the treatment of vascular obstructions.
  • The demographic shift towards an aging population globally correlates with a higher incidence of neurovascular disorders, fostering a sustained market demand for thrombectomy devices.
  • The growing preference for minimally invasive procedures in neurovascular interventions boosts the adoption of thrombectomy devices, reducing patient recovery time and improving overall procedural safety.
  • Heightened awareness regarding the importance of early intervention in neurovascular emergencies fuels the demand for thrombectomy devices, aligning with healthcare initiatives for timely stroke care.
  • Increased healthcare spending, particularly in neurology and vascular care, supports the accessibility and adoption of advanced neurovascular thrombectomy technologies.

Advances in medical technology and an aging population contribute significantly to the increasing incidence of cerebrovascular diseases, such as strokes. As awareness grows regarding the critical importance of timely intervention in neurovascular emergencies, healthcare systems emphasize adopting thrombectomy devices to improve patient outcomes.

The evolving trend in this market reflects a continual focus on technological innovation, with manufacturers striving to develop more efficient and minimally invasive devices. Additionally, collaborations between industry stakeholders, research institutions, and healthcare providers drive the evolution of these devices, leading to a broader range of applications and indications.

The overall trend underscores a commitment to enhancing the accessibility, efficacy, and safety of neurovascular thrombectomy procedures, positioning these devices as essential tools in the contemporary landscape of neurovascular care.

Report Attributes Details
Estimated Market Value (2024E) US$ 744.6 million
Forecasted Market Value (2034F) US$ 1,439.6 million
Global Market Growth Rate (2024 to 2034) 6.8% CAGR
Stent Retriever Segment Growth Rate (2024 to 2034) 6.7% CAGR
Hospital Segment Growth Rate (2024 to 2034) 7.1% CAGR
North America Market Share (2024) 44.3%
Latin America Market Share (2024) 5.6%
Key Companies Profiled
  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc.

What Drives the Neurovascular Thrombectomy Device Market?

“Rising Incidence of Neurovascular Disorders Drives the Market”

The increasing occurrence of neurovascular disorders, particularly strokes, plays a pivotal role in propelling the market forward. With a notable rise in the prevalence of these disorders, there is a heightened demand for advanced medical devices capable of effectively addressing thrombosis and elevating patient outcomes.

As strokes become more widespread, healthcare providers seek innovative solutions, driving the market to develop and offer cutting-edge thrombectomy devices. The growing recognition of the significance of timely intervention in neurovascular conditions further amplifies the need for efficient and specialized medical tools. This surge in demand, fueled by the escalating incidence of neurovascular disorders, positions the market at the forefront of addressing critical healthcare needs.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What Hinders the Expansion of the Market?

“High Costs and Economic Constraints Hinder the Market Expansion”

The substantial costs associated with neurovascular thrombectomy devices present a potential impediment to the market's expansion. These devices often incorporate intricate technologies and advanced materials, increasing production expenses.

Higher costs may pose challenges for healthcare institutions and patients, limiting widespread adoption and accessibility. Economic constraints, particularly budgetary considerations within healthcare settings, may impact the procurement and integration of these devices into routine medical practices.

Additionally, patients may face financial barriers, affecting their ability to avail themselves of these advanced neurovascular interventions. Addressing cost-related challenges becomes crucial for fostering a broader market reach and ensuring that the benefits of neurovascular thrombectomy devices are accessible to a diverse patient population.

What Strategies Can Start-ups Employ to Capitalize on Neurovascular Thrombectomy Device Opportunities?

“Focus on Innovation and Unmet Needs Helps to Strategize Start-ups”

Start-ups have a significant opportunity to thrive in the market by strongly emphasizing innovation and addressing unmet needs within neurovascular care. Prioritizing the development of novel and efficient thrombectomy devices that offer unique features or cater to specific patient populations enables start-ups to carve a distinct niche in the market.

By identifying and addressing gaps in existing solutions, these innovative devices can capture the attention of healthcare professionals seeking enhanced tools for neurovascular interventions. This focus on innovation sets start-ups apart and positions them as contributors to advancements in neurovascular care, fostering potential collaborations and partnerships within the industry.

It serves as a strategic approach to meet current market demands and anticipate and fulfill evolving needs in the ever-progressing landscape of neurovascular healthcare.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Country-wise Insights

North America's neurovascular thrombectomy device market is poised for exceptional growth, projecting a CAGR of 5.9% through 2034. The increase is primarily driven by a rise in market demand in key countries, particularly in the United States and Canada. In 2024, the United States dominated the industry with an estimated 82.3% market share.

Sales for neurovascular thrombectomy devices in Latin America are anticipated to exhibit substantial progress, aiming for a 5.7% CAGR in 2024. In Latin America, Brazil is emerging as the key player in the industry, commanding a significant share of 46.1% in 2024.

Why is the United States Emerging as a Significant Player in the Market?

“Robust Research and Development of Ecosystem Emerges as a Significant Player”

Attribute The United States
Market Value (2024) US$ 272 million
Growth Rate (2024-2034) 5.9% CAGR
Projected Value (2034) US$ 481 million

Due to several key factors, the United States is emerging as a significant player in the market. The country boasts advanced healthcare infrastructure and a robust research and development ecosystem, fostering continuous innovation in medical technologies.

A higher prevalence of neurovascular disorders, particularly strokes, contributes to a substantial demand for cutting-edge thrombectomy devices. Additionally, favorable reimbursement policies and a well-established healthcare system facilitate the adoption of these devices.

The presence of leading medical device manufacturers and a strong regulatory framework further propel the United States into a prominent position in the global market. The combination of technological prowess, a sizable patient population, and supportive healthcare policies cements the United States as a key player in advancing neurovascular care.

What Thrives the Neurovascular Thrombectomy Device Market of Brazil to Grow?

“Increase in Awareness of Neurovascular Disorders Thrives the Brazilian Market”

Attribute Brazil
Market Value (2024) US$ 19 million
Growth Rate (2024-2034) 5.7% CAGR
Projected Value (2034) US$ 33 million

Several factors drive the growth of the market in Brazil. An increasing awareness of neurovascular disorders and the importance of timely interventions has led to a rising demand for advanced thrombectomy devices.

Brazil's growing healthcare infrastructure and investment in medical research contribute to developing and adopting innovative medical technologies, including neurovascular devices.

A larger aging population in Brazil correlates with a higher incidence of neurovascular disorders, creating a sustained market demand. Additionally, collaborative efforts between the government, healthcare institutions, and industry stakeholders to enhance medical technology accessibility will further stimulate the neurovascular thrombectomy device market growth.

As Brazil strives for advancements in neurovascular care, the combination of a growing patient base, improved healthcare infrastructure, and a proactive approach to technology adoption positions the country for continued expansion in the neurovascular thrombectomy device market.

Category-wise Insights

By product type, the stent retriever segment is estimated to hold a 69.8% market share in 2024. By end-user, the hospital is anticipated to hold a market share of 54.3% in 2024.

How is the Increasing Adoption of Stent Retriever Impacting Growth?

“Surge in Treatment for Neurovascular Disorders Fuels the Adoption of Stent Retrievers”

Attribute Stent Retriever
Market Value (2024) US$ 519.7 million
Growth Rate (2024-2034) 6.7% CAGR
Projected Value (2034) US$ 996.7 million

The increasing adoption of stent retrievers is significantly influencing the growth of the neurovascular thrombectomy device market. Stent retrievers are crucial in endovascular procedures for treating neurovascular disorders, particularly ischemic strokes.

These devices effectively remove blood clots by deploying a stent-like mechanism, enhancing the efficiency of thrombectomy procedures. As healthcare practitioners recognize the efficacy and positive outcomes associated with stent retrievers, the demand for these devices is rising.

The evolving trend toward stent retrievers reflects technological advancements and a shift towards minimally invasive approaches, providing patients with improved outcomes and reducing the overall burden of neurovascular conditions. The increasing adoption of stent retrievers underscores their pivotal role in shaping the landscape of neurovascular thrombectomy interventions.

What Drives the Steady Expansion of the Hospital Segment?

“Growth in Awareness of Healthcare Services Drives the Market Segment”

Attribute Hospital
Market Value (2024) US$ 404.1 million
Growth Rate (2024-2034) 7.1% CAGR
Projected Value (2034) US$ 805.6 million

Several key drivers propel the steady expansion of the hospital segment in the neurovascular thrombectomy device market. Hospitals are primary hubs for comprehensive healthcare services, central to diagnosing and treating neurovascular disorders.

The increasing prevalence of these disorders necessitates hospitals equipping themselves with advanced thrombectomy devices for timely interventions. The growing awareness among healthcare professionals about the benefits of neurovascular thrombectomy procedures, coupled with advancements in medical technology, drives hospitals to invest in state-of-the-art devices.

The centralized and controlled environment of hospitals ensures optimal conditions for performing intricate thrombectomy procedures, fostering a preference for hospital-based interventions.

The expansion of the hospital segment indicates the pivotal role these institutions play in providing specialized neurovascular care and underscores the ongoing integration of advanced thrombectomy devices into hospital-based treatment protocols.

Competitive Landscape

The competitive landscape of the neurovascular thrombectomy device market is marked by intense innovation and strategic initiatives. Leading players, including medical device manufacturers and research institutions, focus on developing cutting-edge devices to gain a competitive edge.

Collaboration and partnerships within the industry further contribute to advancements, fostering a dynamic market environment. Key players continually invest in research and development to introduce minimally invasive and highly efficient thrombectomy devices.

Market competition is intensified by the global prevalence of cerebrovascular diseases, driving the demand for innovative solutions. Regulatory compliance and adherence to quality standards are pivotal in establishing market dominance.

A few of the key players in the neurovascular thrombectomy device industry are Medtronic Plc, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Johnson & Johnson Services, Inc., Penumbra Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Acandis GmbH, and Argon Medical Inc

The evolving landscape is characterized by a race to expand applications and indications, with companies striving to address a broader spectrum of neurovascular conditions.

Overall, the neurovascular thrombectomy device market's competitive dynamics underscore the importance of technological prowess, strategic collaborations, and a commitment to advancing patient care in neurovascular interventions.

Some recent developments in the Neurovascular Thrombectomy Device Market

  • In February 2022, Imperative Care, Inc. introduced the Zoom POD Aspiration Tubing, expanding its ischemic stroke product lineup. This includes the Zoom 88 Large Distal Platform for neurovascular access, four Zoom Aspiration Catheters in diverse sizes, and the Zoom Pump accompanied by accessories.
  • In February 2022, Cerenovus unveiled Emboguard, a state-of-the-art balloon guide catheter designed for endovascular procedures, particularly for patients with acute ischemic stroke.

These launches signify a commitment to advancing neurovascular interventions, offering a broader range of tools for physicians, and underscoring the continuous innovation within the medical technology landscape.

Segmentation of Neurovascular Thrombectomy Device Market Research

  • By Product Type :

    • Stent Retriever
    • Aspiration Catheter
  • By End User :

    • Hospitals
    • Neuro-Catheterization Labs
    • Specialized Neurosurgery Centres
  • By Region :

    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • South Asia and Pacific
    • East Asia
    • Middle East and Africa

- FAQs -

What was the value of the neurovascular thrombectomy device market in 2019?

The global neurovascular thrombectomy device market was worth US$ 535.3 million in 2019.

What is the outlook for the neurovascular thrombectomy device market in 2024?

The market for neurovascular thrombectomy devices is likely to be valued at US$ 744.6 million in 2024.

What will be the anticipated value of the neurovascular thrombectomy device market in 2034?

By 2034, sales of neurovascular thrombectomy devices are poised to reach US$ 1,439.6 million.

What is the projected forecast CAGR for the market from 2024 to 2034?

The market is anticipated to expand at a CAGR of 6.8% from 2024 to 2034.

At what rate is the market in North America predicted to grow?

The market in North America is forecasted to expand at a CAGR of 5.9% through 2034.

- Also of Interest -

Peripheral Vascular Devices Market

Peripheral Vascular Devices Market Analysis by Angioplasty Stents, Angioplasty Balloon Catheters, EVAR Stent Grafts, Plaque Modification Devices, and Others from 2023 to 2033

Vascular Grafts Market

Vascular Grafts Market Analysis by Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair, and Hemodialysis Access from 2023 to 2033

Vascular Closure Devices Market

Vascular Closure Devices Market Analysis By Type (Active Approximators, Passive Approximators & External Hemostatic Devices) By Access (Formal & Radial), By Procedure (Interventional Cardiology Interventional Radiology/Vascular Surgeries) & By Region – Global Market Insights 2022 to 2026

Cerebral Angiography Market

Cerebral Angiography Market By Technology (Magnetic Resonance Angiography, Computed Tomography, Ultrasound, Nuclear Imaging, X-ray), By End User (Hospitals, Diagnostic Imaging Centers) & Region - Global Market Insights 2022 to 2027

Neurovascular Thrombectomy Device Market

Schedule a Call